1 Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON, Canada 
2 One Health Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada 
3 Antimicrobial Resistance Division, Infectious Diseases Prevention and Control Branch, Public Health Agency of Canada, Ottawa, ON, Canada 
4 University of Ottawa, Department of Civil Engineering, Ottawa, ON, Canada 
5 Public Health Laboratory, Alberta Precision Laboratory, Edmonton, AB, Canada 
6 Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada 
7 Department of Pediatrics, University of Alberta, Edmonton, AB, Canada 
8 Toronto Public Health, Toronto, ON, Canada 
9 Canadian Field Epidemiology Program, Emergency Management, Public Health Agency of Canada 
10 None
1. SARS-CoV-2 RNA has been detected and quantified in sewage in many locations worldwide (as of June 2021, 55 countries have pilot programs for a wastewater surveillance system with 2,287 sampling sites [15])
2. The common practice is to use the detection of SARS-CoV-2 in wastewater as a signal for COVID-19 (re)introduction in a community and/or perform trend analysis in parallel with clinical surveillance of COVID-19
None
31, 32, 16, 33
34, 35, 36
37, 38
39, 33
40, 41
42
S: Susceptible 
E: Exposed (infected but not yet infectious)
J: Symptomatically infected who will later become hospitalized
I: Recovered without hospitalization during active COVID-19
A: Asymptomatically infected
H: Hospitalized
Z: Recovered and no longer infectious but still shedding virus in faeces
R: Fully recovered and permanently immune but not shedding anymore
D: Deceased
None
46 - exponential viral decay
168 - sedimentation and resuspension
170 - reshapes the initial deposited concentration
172 - sampled viral concentration at time t
174 - daily decay rate of SARS-CoV-2
176 - single hydrodynamic pulse per day
178 - mean delay time
180 - standard deviation
182 - sample transportation
184 - laboratory processing time
186 - reporting lags
188 - transport of RNA particles in the sewer system
190 - fraction ρ of symptomatic incidence
192 - instantaneous identiﬁcation
194 - total incidence
196 - six wastewater sampling sites
198 - Gold Bar in Edmonton
200 - Robert O. Pickard Environmental Centre in Ottawa
202 - Toronto Ashbridges Bay
204: Wastewater samples
206: Wastewater treatment plant
208: SARS-CoV-2 RNA concentration
210: Ultracentrifugal filter device
212: 4000 × g centrifugation
214: MagNA Pure 96 DNA and Viral NA Large Volume Kit
216: Plasma External Lysis 4.0 protocol
218: 0.5 mm zirconia-silica beads
220: Bead Mill 24 Homogenizer
222: 12000 × g centrifugation
224: US-CDC N1 and N2 primers
226: 24-hour composite primary sludge samples
228: 10,000g centrifugation
230: Qiagen RNeasy PowerMicrobiome kit
232: N1 and N2 gene regions
234: Total solid suspension
236: Pepper mild mottle virus
238: Average normalized concentration
240: Clinical cases and hospital admissions
53 - Canadian Blood Services
S1 - Supplementary File S1
50,000 - prior ABC iterations
100 - smallest errors
2 × 10−3 - acceptance ratio
8 - weighted trajectory matching
1 - normalized to 1
9 - Equation 8
10 - Equation 9
54 - Approximate Bayesian Computation
1 - wC = wH = 1
0 - wW = 0
1 - wW = 1
0 - wH = wC = 0
1a - Equation 1a
None
2. Equation
3.5 Simulations
268 Detection timing differential
270 SARS-CoV-2
272 Limit of detection of the laboratory method
274 Reported detection differential
276 Model parameters
278 COVID-19 reporting
280 Proportion of COVID-19
282 Vaccination
284 Transmission rate
286 Proportion of asymptomatic infection
288 Infection-permissive vaccine
290 Transmission rate
292 Level of SARS-CoV-2
294 Epidemiological variables
296 Canadian cities
298 Clinical and wastewater surveillances
300 Key epidemiological variables
302 Data stream
304 Different data sources
12 / 43
306
308
310
312
314
316
318
320
322
324
326
328
330
332
334
336
338
340
None
7-19 15:54:19-04:00 13 / 43
medRxiv preprint doi: https://doi.org/10.1101/2021.07.19.21260773
saved on 2021-07-19 15:54:19-04:00 14 / 43
medRxiv preprint doi: https://doi.org/10.1101/2021.07.19.21260773
saved on 2021-07-19 15:54:19-04:00 15 / 43
medRxiv preprint doi: https://doi.org/10.1101/2021.07.19.21260773
342 4.1.3 Forecasts
None
434 - estimates for cumulative incidence
436 - seroprevalence levels from cohorts of blood donors independently observed in the three cities
438 - discordant signals can occur
440 - wave observed from the reported clinical cases
442 - undetermined events in this particular sewershed at that specific time
444 - effective reproduction numbers inferred from wastewater data only
446 - EpiEstim
448 - clinical surveillance
450 - epidemiological metrics
452 - triangulate the state of an epidemic
454 - COVID-19 pandemic
456 - wastewater surveillance
458 - simpler smoothing techniques
460 - WBS
462 - machine learning techniques
464 - epidemiological mechanisms
466 - in silico experiments
468 - wastewater signal
470 - laboratory analysis
472 - SARS-CoV-2
474 - shipment time
476 - incubation period
478 - clinical cases reports
480 - contact tracing
482 - clinical surveillance
484 - relative timing
486 - public health interventions
488 - SARS-CoV-2 in wastewater
490 surveillance may be inferior to clinical surveillance to identify sharp declines in transmis- sion
491 Figure 7
492 faecal shedding
494 Figure 2
496 discordant signals between wastewater and clinical surveillances
497 Figure 8
498 proportion of asymptomatic infections
500 real data
502 SARS-CoV-2 in wastewater
504 variations of the total faecal mass shedded
505 PMMV-normalization
506 TSS-normalization
508 flow dynamics
510 particles binding of SARS-CoV-2 in wastewater
512 Figure 46
514 mean transit time
516 seroprevalence level
518 seroreversion
520 infection-permissive vaccination
522 proportion of vaccinated individuals
524 late 2020
525 Figure 66
None
23 / 43
530 532
534
536 538 540 542 544
546
548
550
552
554
556
558
560
α asymptomatic proportion 0.316
δ proportion of death from hospitalized 0.19
Length of hospital stay 10 day
Infectious period 24 day
Reporting lag between sampling date and reporting date in days 2 day
11 - J. M. Fioretti, T. M. Fumian, M. S. Rocha, I. A. L. Dos Santos, F. A. Carvalho-Costa, M. R. de Assis, J. S. Rodrigues, J. P. G. Leite, and M. P. Miagostovich. Surveillance of Noroviruses in Rio De Janeiro, Brazil: Occurrence of New GIV Genotype in Clinical and Wastewater Samples. Food Environ Virol, 10(1):1–6, 03 2018.
12 - H. Asghar, O. M. Diop, G. Weldegebriel, F. Malik, S. Shetty, L. El Bassioni, A. O. Akande, E. Al Maamoun, S. Zaidi, A. J. Adeniji, C. C. Burns, J. Deshpande, M. S. Oberste, and S. A. Lowther. Environmental Surveillance for Polioviruses in the Global Polio Eradication Initiative. J Infect Dis, 210 Suppl 1:294–303, Nov 2014.
13
20 G. La Rosa, M. Iaconelli, P. Mancini, G. Bonanno Ferraro, C. Veneri, L. Bonadonna, L. Lucentini, and E. Suﬀredini. First detection of SARS-CoV-2 in untreated wastewaters in Italy. Sci Total Environ, 736:139652, Sep 2020.
21 D. A. Larsen and K. R. Wigginton. Tracking COVID-19 with wastewater. Nat Biotechnol, 38(10):1151–1153, 10 2020.
22 W. Randazzo, P. Truchado, E. Cuevas-Ferrando, P. Simon, A. Allende, and G. Sanchez. SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res, 181:115942, Aug 2020.
23 P. M. D’Aoust, E. Mercier, D. Montpetit, J. J. Jia, I. Alexandrov, N. Neault, A. T. Baig, J. Mayne, X
34 X. Li, S. Zhang, J. Shi, S. P. Luby, and G. Jiang. Uncertainties in estimating SARS-CoV-2 prevalence by 674 wastewater-based epidemiology. Chem Eng J, 415:129039, Jul 2021.
35 Y. Zhu, W. Oishi, C. Maruo, M. Saito, R. Chen, M. Kitajima, and D. Sano. Early warning of COVID-19 via 676 wastewater-based epidemiology: potential and bottlenecks. Sci Total Environ, 767:145124, May 2021.
36 Mia Rabson. Researchers looking for clues to the COVID-19 pandemic in city sewers. Global News, The 678 Canadian Press, Apr 2021.
37 David L. Jones, Marcos Quintela Baluja, David W. Graham, Alexander Corbishley, James E. McDonald, 680 Shelagh K. Malham, Luke S. Hillary, Thomas R. Connor, William H. Gaze, Ines B. Moura, Mark H. Wilcox, and Kata Farkas. Shedding of sars-cov-2 in feces and
47 A. Kayode Coker. Chapter eight - residence time distributions in ﬂow reactors. pages 663–761, 2001.
48 City of Ottawa. Wastewater collection and treatment, Robert O. Pickard Environmental Centre (ROPEC). Online, 2021.
49 Toronto Water. City of Toronto, Ashbridges Bay wastewater treatment plant annual report of 2020. Online, 2021.
50 Toronto Water. City of Toronto, Humber wastewater treatment plant annual report of 2020. Online, 2021.
51 Toronto Water. City of Toronto, Highland Creek wastewater treatment plant annual report of 2020. Online, 2021.
52 Statistics Canada. 2016 Census of Canada via Toronto Public Health. 2016.
53 Canadian Blood Services. Covid-19 public seroprevalence report: April 2020 to january 2021. Technical report, Canadian Blood Services, 2021.
54 Mark A Beaumont, Wenyang Zhang, and David J Balding. Approximate Bayesian Computation in Population Genetics. Genetics, 162(4):2025–2035, 12 2002.
55 C. Hollingsworth D. Keeling M. Vegvari C. Baggaley R. Maddren R. Anderson, R. Donnelly.
[61] N. Sims and B. Kasprzyk-Hordern. Environ IntFuture perspectives of wastewater-based epidemiology: Moni- 748 toring infectious disease spread and resistance to the community level. Environ Int, 139:105689, 06 2020.
[62] Jana S. Huisman, J´er´emie Scire, Lea Caduﬀ, Xavier Fernandez-Cassi, Pravin Ganesanandamoorthy, Anina 750 Kull, Andreas Scheidegger, Elyse Stachler, Alexandria B. Boehm, Bridgette Hughes, Alisha Knudson, Aaron Topol, Krista R. Wigginton, Marlene K. Wolfe, Tamar Kohn, Christoph Ort, Tanja Stadler, and Timothy R. 752 Julian. Wastewater-based estimation of the eﬀective reproductive number of sars-cov-2. medRxiv, 2021.
[63] A. Xiao, F. Wu, M. Bushman, J. Zhang, M. Imakaev, P. R. Chai, C. Duvallet, N. Endo, T. B
71 C. S. McMahan, S. Self, L. Rennert, C. Kalbaugh, D. Kriebel, D. Graves, J. A. Deaver, S. Popat, T. Karanﬁl, and D. L. Freedman. medRxivCOVID-19 Wastewater Epidemiology: A Model to Estimate Infected Popula- tions. medRxiv, Nov 2020.
72 A. N. M. Kraay, A. F. Brouwer, N. Lin, P. A. Collender, J. V. Remais, and J. N. S. Eisenberg. Proc Natl Acad Sci U S AModeling environmentally mediated rotavirus transmission: The role of temperature and hydrologic factors. Proc Natl Acad Sci U S A, 115(12):E2782–E2790, 03 2018.
73 G. La Rosa, P. Mancini, G. Bonanno Ferraro, C. Veneri, M. Iaconelli, L. Lucentini, L. Bonadonna, S. Brusaferro, D. Brandtner, A.
81 - Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs
82 - Sars-cov-2 viral dynamics in acute infections
83 - Viral kinetics of sars-cov-2 over the preclinical, clinical, and postclinical period
84 - Persistent SARS-CoV-2 RNA Shedding without Evidence of Infectiousness: A Cohort Study of Individuals with COVID-19
85 - Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples
86 - Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients
87 - Faecal shedding models for sars-cov-2 rna amongst hospitalised patients and implications for wastewater-based epidemiology
[88] K. Mizumoto, K. Kagaya, A. Zarebski, and G. Chowell. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill, 25(10), 03 2020.
[89] H. Nishiura, T. Kobayashi, T. Miyama, A. Suzuki, S. M. Jung, K. Hayashi, R. Kinoshita, Y. Yang, B. Yuan, A. R. Akhmetzhanov, and N. M. Linton. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis, 94:154–155, 05 2020.
[90] D. Buitrago-Garcia, D. Egli-Gany, M. J. Counotte, S. Hossmann, H. Imeri, A. M. Ipekci, G. Salanti, and N. Low. Occurrence and transmission potential of asymptomatic and presymptomatic
902 - Figure S1
904 - 
906 - 
908 - 
910 - 
912 - 
914 - 
916 - break times bi
918 - parameter space
920 - normal distributions
922 - coeﬃcient of variation of 0.5
924 - A-2 Relative infectiousness
926 - Equation 1a
928 - nI
930 - φk
932 - 12 days
934 - nI
936 - Ik
938 - log viral load
940 - ˜ψ = (3, 6, 5, 4, 3, 2)
942 - 10 days
944 - A-3 Respiratory and faecal Viral kinetics
None.
16 - viral RNA undergoes various hydrodynamic processes
33 - RNA decay resulting from harsh wastewater environment
98 - complex hydraulic models simulate the in-fluid transportation of the water contaminants
99 - complex hydraulic models simulate the in-fluid transportation of the water contaminants
100 - complex hydraulic models simulate the in-fluid transportation of the water contaminants
101 - complex hydraulic models simulate the in-fluid transportation of the water contaminants
102 - attachments of microorganisms to sediments
103 - microorganisms’ transportation by the flow velocity
104 - attachments of microorganisms to sediments
105 - physical factors such as dissolving process
106 - increase in-stream microorganism’s concentration
107 - increase in-stream microorganism’s concentration
None
42 / 43
43 / 43
